Collectively, inactivating Bcl-XL might be a treatment strategy for neuropathic pain in T1DM, and the results jointly indicate that in DN, Bcl-XL might be an upstream modulator that regulates the dynamic balance of ER stress and UPS activity for maintaining functional and physiological protein activity. This evidence concerns the gene BCL2L1 and type 1 diabetes mellitus.